Mexiletine Hydrochloride Global Market Report 2025
상품코드:1855922
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
염산 멕실레틴 시장 규모는 최근 강력하게 성장하고 있습니다. 2024년 11억 9,000만 달러에서 2025년에는 12억 9,000만 달러로, CAGR 8.8%로 확대합니다. 이 기간의 성장은 심혈관 질환의 유병률 증가, 부정맥 사례 증가와 함께 고령화, 항부정맥제 치료에 대한 인식 증가, 병원 처방 급증, 제네릭 의약품의 보급, 선진국의 의료 서비스 접근성 향상 등에 기인합니다.
멕시레틴 염산염 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 8.5%로 17억 9,000만 달러로 성장할 것입니다. 예측 기간 중 예상되는 성장의 원동력은 신흥 국가의 의료 접근성 확대, 소매 약국 수요 증가, 저렴한 제네릭 의약품의 보급, 의료 인프라 개선, 개발도상국의 규제 승인 증가, 보편적 의료보험제도에 따른 의료비 지출 증가 등입니다. 이 기간 중 예상되는 주요 동향으로는 서방형 제제의 기술 발전, 맞춤형 의료의 발전, 약물전달 시스템의 혁신, 유전자 프로파일링 연구에 대한 투자, 신약 개발에 대한 인공지능 적용 개선, 근긴장성 이영양증 치료와 같은 새로운 적응증에 대한 탐구 등이 있습니다.
멕시레틴 염산염은 심각한 부정맥, 특히 심장 하부의 심실성 부정맥 치료에 사용되는 처방약입니다. 나트륨 채널 차단제로서 심장의 전기적 활동을 안정시키고 규칙적인 심장 박동을 유지하는 데 도움을 줍니다. 또한 과활동성 신경이나 근육 기능 장애로 인한 증상을 완화하기 위해 특정 신경 장애나 근육 장애에도 처방될 수 있습니다.
염산 멕시레틴의 주요 제품 유형에는 캡슐, 정제, 주사제 등이 있습니다. 캡슐은 정확한 양의 약물을 함유한 용해 가능한 껍질을 가진 고형제이며, 쉽게 삼킬 수 있고 방출이 조절되는 고형제입니다. 유통 채널에는 병원 약국, 소매 약국, 온라인 약국, 기타 매장이 포함됩니다. 주요 용도는 부정맥, 신경병성 통증, 근긴장 장애 등의 치료입니다. 최종사용자에는 병원, 클리닉, 재택 요양 현장, 기타 의료 서비스 프로바이더가 포함됩니다.
2025년 봄, 미국의 갑작스러운 관세 인상과 이에 따른 무역 마찰은 제약회사에 심각한 영향을 미치고 있습니다. 이익이 적은 제네릭 의약품 제조업체는 특히 취약하며, 일부 기업은 수익성이 낮은 의약품의 생산을 축소하기도 합니다. 생명공학 기업은 관세와 관련된 특수 시약의 부족으로 인해 임상시험이 지연되고 있습니다. 이에 업계는 인도와 유럽에서 원료의약품 생산을 확대하고, 재고 비축을 늘리며, 필수의약품의 무역 면제를 요구하고 있습니다.
염산 멕시레틴 시장 조사 보고서는 염산 멕시레틴 산업 세계 시장 규모, 지역 점유율, 염산 멕시레틴 시장 점유율을 가진 경쟁사, 염산 멕시레틴 시장 부문, 시장 동향, 비즈니스 기회 등 염산 멕시레틴 시장 통계를 제공하는 The Business Research Company의 최신 보고서 시리즈 중 하나입니다. 이 멕시레틴 염산염 시장 조사 보고서는 업계의 현재와 미래 시나리오를 자세히 분석하여 필요한 모든 것을 완전한 관점으로 제공합니다.
심혈관 질환의 유병률 증가는 향후 수년간 멕시레틴 염산염 시장의 성장을 가속할 것으로 예측됩니다. 심혈관질환에는 관상동맥성 심장질환, 뇌혈관질환, 기타 심장질환 등 심장과 혈관에 영향을 미치는 질환이 포함됩니다. 이러한 질병 증가는 인구의 고령화와 좌식 생활 습관과 관련이 있으며, 평균 수명의 연장과 신체 활동 감소 및 건강에 해로운 식습관이 결합되어 심장 관련 문제의 위험을 크게 증가시키고 있습니다. 멕시레틴 염산염은 심장의 특정 전기 신호와 나트륨 채널을 차단하여 불규칙한 심장 리듬을 안정화시킴으로써 작용합니다. 따라서 심실성 부정맥 및 심혈관계 질환에 따른 기타 심장 리듬 장애에 효과적인 치료제가 될 수 있습니다. 예를 들어 호주 정부 기관인 호주 보건 복지 연구소는 2021년 관상동맥 심장질환으로 인한 의사 진단 사망자 수가 2021년 1만 4,100명에서 2022년 1만 4,900명으로 증가할 것으로 보고했습니다. 따라서 심혈관 질환 발생률 증가는 멕시레틴 염산염 시장의 성장을 가속하고 있습니다.
멕시레틴 염산염 시장의 주요 기업은 다양한 강도로 제공되는 제네릭 캡슐 제제와 같은 혁신적인 제품을 개발하여 접근성을 개선하고, 중증 심장병 환자에게 합리적인 가격의 치료 옵션을 제공합니다. 이러한 제네릭 캡슐은 다양한 용법 및 용량으로 제공되는 비용 효율적인 대체품으로, 의사가 개별 환자의 필요에 따라 치료할 수 있도록 하는 동시에 구매하기 쉬운 가격 및 접근성을 향상시킵니다. 예를 들어 2022년 1월 미국 제약사 세노아즈 파마슈티컬스(Senors Pharmaceuticals Inc.)는 미국 제네릭 의약품 상위 5개사 중 한 곳과 제휴하여 150mg, 200mg, 250mg 강도의 멕시레틴 염산염 캡슐 USP를 출시했습니다. 멕시레틴은 심장 세포의 나트륨 채널을 차단하고, 심근막을 안정화시키고, 비정상적인 전기적 활동을 억제함으로써 클래스 IB 항부정맥제 역할을 합니다. 이를 통해 생명을 위협하는 심실성 부정맥을 예방하고 중증 부정맥 환자의 심장 리듬 안정성을 개선합니다. 표적 작용기전은 환자의 생존과 장기적인 심장 건강을 위해 심실성 빈맥성 부정맥의 신속하고 지속적인 조절이 필요한 임상 상황에서 특히 유용합니다.
2025년 1월, 염산 멕시레틴을 전문으로 하는 인도 제약회사 Lupin Limited는 Avas Pharmaceuticals SRL과 제휴하여 이탈리아에서 NaMuscla를 출시했습니다. 본 치료는 성인의 비발육성 근긴장이상증에 대한 대증요법입니다. 이번 제휴를 통해 루핀 리미티드와 아바스 파마슈티컬스(Avas Pharmaceuticals SRL)는 이탈리아 시장에 근긴장이상증 치료제로서는 최초로 승인된 치료제를 출시하여 미충족 의료 수요를 충족시키고, 환자의 접근성을 안정화하며, 안전하고 효과적인 치료로 삶의 질을 향상시키는 것을 목표로 하고 있습니다. 삶의 질을 향상시키는 것을 목표로 합니다. 아바스 파마슈티컬스(Avas Pharmaceuticals SRL)는 이탈리아에 본사를 두고 있으며, 희귀질환 및 특수질환에 대한 혁신적인 치료제의 상용화를 목표로 하는 기업입니다.
염산 멕시레틴 시장은 멕시틸과 남스크라의 매출로 구성되어 있습니다. 이 시장의 가치는 '팩토리 게이트'의 가치이며, 다른 업체(다운스트림 제조업체, 도매업체, 유통업체, 소매업체 포함) 또는 최종 고객에게 직접 판매하든, 상품의 제조업체 또는 제작자가 판매한 상품의 가치입니다. 이 시장에서 상품의 가치에는 상품을 만든 사람이 판매하는 관련 서비스도 포함됩니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 염산 멕실레틴 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 염산 멕실레틴 시장 : 성장률 분석
세계의 염산 멕실레틴 시장 실적 : 규모와 성장, 2019-2024
세계의 염산 멕실레틴 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 염산 멕실레틴 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 염산 멕실레틴 시장 : 제품 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
캡슐제
태블릿
주사제
기타 제품 유형
세계의 염산 멕실레틴 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원 약국
소매 약국
온라인 약국
기타 유통 채널
세계의 염산 멕실레틴 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
부정맥
신경병증성 통증
근긴장성 장애
기타 용도
세계의 염산 멕실레틴 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
클리닉
홈케어
기타 최종사용자
세계의 염산 멕실레틴 시장 : 서브 세분화 캡슐, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
서방형 캡슐
즉시 방출 캡슐
세계의 염산 멕실레틴 시장 : 서브 세분화 정제, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
필름 코팅정
츄어블정
분산성 정제
세계의 염산 멕실레틴 시장 : 서브 세분화 주사제, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
정맥주사제
근육내 주사
피하 주사
세계의 염산 멕실레틴 시장 : 서브 세분화 기타 제품 유형, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구 현탁액
외용액
배합제
제7장 지역별·국가별 분석
세계의 염산 멕실레틴 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 염산 멕실레틴 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
염산 멕실레틴 시장 : 경쟁 구도
염산 멕실레틴 시장 : 기업 개요
Teva Pharmaceuticals Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
Macleods Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis
Cipla Limited Overview, Products and Services, Strategy and Financial Analysis
Lupin Limited Overview, Products and Services, Strategy and Financial Analysis
Alembic Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
ANI Pharmaceuticals Inc.
Taj Pharmaceuticals Limited
Biophore India Pharmaceuticals Pvt. Ltd.
Professional Compounding Centers of America Inc.(PCCA)
Medichem S.A.
Camber Pharmaceuticals Inc.
Ingenus Pharmaceuticals LLC
AGC Pharma Chemicals Europe S.L.U.
Rivopharm S.A.
Kalintis Healthcare Pvt. Ltd.
Senores Pharmaceuticals Inc.
Midas Pharma GmbH
Tooba Pharmaceuticals Private Limited
Changzhou Yabang Pharmaceutical Co. Ltd.
Shreeji Pharma International
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
염산 멕실레틴 시장 2029 : 새로운 기회를 제공하는 국가
염산 멕실레틴 시장 2029 : 새로운 기회를 제공하는 부문
염산 멕실레틴 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Mexiletine hydrochloride is a prescription medication used to treat serious irregular heart rhythms, particularly ventricular arrhythmias in the lower chambers of the heart. As a sodium channel blocker, it stabilizes the heart's electrical activity and helps maintain a regular heartbeat. It may also be prescribed for certain nerve and muscle disorders to reduce symptoms caused by overactive nerves or muscle dysfunction.
The primary product types of mexiletine hydrochloride include capsules, tablets, injections, and other forms. Capsules are solid dosage forms with a dissolvable shell containing precise amounts of medication, allowing for easy swallowing and controlled release. Distribution channels include hospital pharmacies, retail pharmacies, online pharmacies, and other outlets. Key applications include treatment of arrhythmias, neuropathic pain, myotonic disorders, and other indications. End-users include hospitals, clinics, homecare settings, and other healthcare providers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The mexiletine hydrochloride market research report is one of a series of new reports from The Business Research Company that provides mexiletine hydrochloride market statistics, including mexiletine hydrochloride industry global market size, regional shares, competitors with the mexiletine hydrochloride market share, mexiletine hydrochloride market segments, market trends, and opportunities, and any further data you may need to thrive in the mexiletine hydrochloride industry. This mexiletine hydrochloride market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The mexiletine hydrochloride market size has grown strongly in recent years. It will grow from $1.19 billion in 2024 to $1.29 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth observed during the historical period is attributed to the rising prevalence of cardiovascular diseases, an aging population with increasing cases of arrhythmia, heightened awareness of antiarrhythmic drug therapies, a surge in hospital-based prescriptions, greater penetration of generic drugs, and improved healthcare accessibility in developed regions.
The mexiletine hydrochloride market size is expected to see strong growth in the next few years. It will grow to $1.79 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. Growth expected in the forecast period is driven by expanding healthcare access in emerging economies, increasing demand from retail pharmacies, wider adoption of affordable generic drugs, development of healthcare infrastructure, a rise in regulatory approvals in developing countries, and higher healthcare spending supported by universal coverage programs. Key trends anticipated during this period include technological progress in sustained release formulations, advances in personalized medicine, innovations in drug delivery systems, investments in genetic profiling research, improvements in artificial intelligence applications for drug discovery, and the exploration of new indications such as treatments for myotonic dystrophy.
The rising prevalence of cardiovascular diseases is expected to drive the growth of the mexiletine hydrochloride market in the coming years. Cardiovascular diseases include disorders affecting the heart and blood vessels, such as coronary heart disease, cerebrovascular disease, and other cardiac conditions. The increase in these diseases is linked to aging populations and sedentary lifestyles, as longer life expectancy combined with reduced physical activity and unhealthy diets significantly raise the risk of heart-related issues. Mexiletine hydrochloride functions by blocking specific electrical signals and sodium channels in the heart, stabilizing irregular heart rhythms. This makes it an effective treatment for ventricular arrhythmias and other cardiac rhythm disorders associated with cardiovascular diseases. For example, in December 2023, the Australian Institute of Health and Welfare, a government agency in Australia, reported that doctor-certified deaths due to coronary heart disease rose to 14,900 in 2022, up from 14,100 in 2021. Therefore, the increasing incidence of cardiovascular diseases is propelling growth in the mexiletine hydrochloride market.
Leading companies in the mexiletine hydrochloride market are developing innovative products such as generic capsule formulations available in multiple strengths to improve accessibility and offer affordable treatment options for patients with severe cardiac conditions. These generic capsules are cost-effective alternatives available in various dosages, allowing physicians to tailor treatments to individual patient needs while enhancing affordability and access. For example, in January 2022, Senores Pharmaceuticals Inc., a pharmaceutical company based in the United States, launched Mexiletine Hydrochloride Capsules USP in 150 mg, 200 mg, and 250 mg strengths through a collaboration with one of the top five generic pharmaceutical companies in the U.S. Mexiletine acts as a class IB antiarrhythmic agent by blocking sodium channels in cardiac cells, stabilizing the myocardial membrane, and suppressing abnormal electrical activity. This helps prevent life-threatening ventricular arrhythmias and improves cardiac rhythm stability in patients with severe arrhythmic conditions. Its targeted mechanism of action is especially valuable in clinical settings requiring rapid and sustained control of ventricular tachyarrhythmias for patient survival and long-term heart health.
In January 2025, Lupin Limited, a pharmaceutical company from India specializing in mexiletine hydrochloride, partnered with Avas Pharmaceuticals SRL to introduce NaMuscla in Italy. This treatment is intended for the symptomatic management of myotonia in adults with non-dystrophic myotonic disorders. Through this partnership, Lupin Limited and Avas Pharmaceuticals SRL aim to bring the first licensed treatment for myotonia to the Italian market, addressing unmet medical needs, ensuring consistent patient access, and improving quality of life with a safe and effective therapy. Avas Pharmaceuticals SRL is an Italy-based company dedicated to commercializing innovative treatments for rare and specialized diseases.
Major players in the mexiletine hydrochloride market are Teva Pharmaceuticals Industries Ltd., Macleods Pharmaceuticals Limited, Cipla Limited, Lupin Limited, Alembic Pharmaceuticals Limited, ANI Pharmaceuticals Inc., Taj Pharmaceuticals Limited, Biophore India Pharmaceuticals Pvt. Ltd., Professional Compounding Centers of America Inc. (PCCA), Medichem S.A., Camber Pharmaceuticals Inc., Ingenus Pharmaceuticals LLC, AGC Pharma Chemicals Europe S.L.U., Rivopharm S.A., Kalintis Healthcare Pvt. Ltd., Senores Pharmaceuticals Inc., Midas Pharma GmbH, Tooba Pharmaceuticals Private Limited, Changzhou Yabang Pharmaceutical Co. Ltd., Shreeji Pharma International.
North America was the largest region in the mexiletine hydrochloride market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in mexiletine hydrochloride report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the mexiletine hydrochloride market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The mexiletine hydrochloride market consists of sales of mexitil and namuscla. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Mexiletine Hydrochloride Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on mexiletine hydrochloride market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for mexiletine hydrochloride ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mexiletine hydrochloride market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Capsules; Tablets; Injection; Other Product Types
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
3) By Application: Arrhythmias; Neuropathic Pain; Myotonic Disorders; Other Applications
4) By End-User: Hospitals; Clinics; Homecare; Other End-Users
Subsegments:
1) By Capsules: Extended Release Capsules; Immediate Release Capsules
2) By Tablets: Film Coated Tablets; Chewable Tablets; Dispersible Tablets
3) By Injection: Intravenous Injection; Intramuscular Injection; Subcutaneous Injection
4) By Other Product Types: Oral Suspension; Topical Solution; Compounded Formulations
Companies Mentioned: Teva Pharmaceuticals Industries Ltd.; Macleods Pharmaceuticals Limited; Cipla Limited; Lupin Limited; Alembic Pharmaceuticals Limited; ANI Pharmaceuticals Inc.; Taj Pharmaceuticals Limited; Biophore India Pharmaceuticals Pvt. Ltd.; Professional Compounding Centers of America Inc. (PCCA); Medichem S.A.; Camber Pharmaceuticals Inc.; Ingenus Pharmaceuticals LLC; AGC Pharma Chemicals Europe S.L.U.; Rivopharm S.A.; Kalintis Healthcare Pvt. Ltd.; Senores Pharmaceuticals Inc.; Midas Pharma GmbH; Tooba Pharmaceuticals Private Limited; Changzhou Yabang Pharmaceutical Co. Ltd.; Shreeji Pharma International
3. Mexiletine Hydrochloride Market Trends And Strategies
4. Mexiletine Hydrochloride Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Mexiletine Hydrochloride Growth Analysis And Strategic Analysis Framework
5.1. Global Mexiletine Hydrochloride PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Mexiletine Hydrochloride Market Growth Rate Analysis
5.4. Global Mexiletine Hydrochloride Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Mexiletine Hydrochloride Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Mexiletine Hydrochloride Total Addressable Market (TAM)
6. Mexiletine Hydrochloride Market Segmentation
6.1. Global Mexiletine Hydrochloride Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Capsules
Tablets
Injection
Other Product Types
6.2. Global Mexiletine Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other Distribution Channels
6.3. Global Mexiletine Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Arrhythmias
Neuropathic Pain
Myotonic Disorders
Other Applications
6.4. Global Mexiletine Hydrochloride Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Homecare
Other End-Users
6.5. Global Mexiletine Hydrochloride Market, Sub-Segmentation Of Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Extended Release Capsules
Immediate Release Capsules
6.6. Global Mexiletine Hydrochloride Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Film Coated Tablets
Chewable Tablets
Dispersible Tablets
6.7. Global Mexiletine Hydrochloride Market, Sub-Segmentation Of Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous Injection
Intramuscular Injection
Subcutaneous Injection
6.8. Global Mexiletine Hydrochloride Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Suspension
Topical Solution
Compounded Formulations
7. Mexiletine Hydrochloride Market Regional And Country Analysis
7.1. Global Mexiletine Hydrochloride Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Mexiletine Hydrochloride Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Mexiletine Hydrochloride Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Mexiletine Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Mexiletine Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Mexiletine Hydrochloride Market
9.1. China Mexiletine Hydrochloride Market Overview
9.2. China Mexiletine Hydrochloride Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Mexiletine Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Mexiletine Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Mexiletine Hydrochloride Market
10.1. India Mexiletine Hydrochloride Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Mexiletine Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Mexiletine Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Mexiletine Hydrochloride Market
11.1. Japan Mexiletine Hydrochloride Market Overview
11.2. Japan Mexiletine Hydrochloride Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Mexiletine Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Mexiletine Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Mexiletine Hydrochloride Market
12.1. Australia Mexiletine Hydrochloride Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Mexiletine Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Mexiletine Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Mexiletine Hydrochloride Market
13.1. Indonesia Mexiletine Hydrochloride Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Mexiletine Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Mexiletine Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Mexiletine Hydrochloride Market
14.1. South Korea Mexiletine Hydrochloride Market Overview
14.2. South Korea Mexiletine Hydrochloride Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Mexiletine Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Mexiletine Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Mexiletine Hydrochloride Market
15.1. Western Europe Mexiletine Hydrochloride Market Overview
15.2. Western Europe Mexiletine Hydrochloride Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Mexiletine Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Mexiletine Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Mexiletine Hydrochloride Market
16.1. UK Mexiletine Hydrochloride Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Mexiletine Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Mexiletine Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Mexiletine Hydrochloride Market
17.1. Germany Mexiletine Hydrochloride Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Mexiletine Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Mexiletine Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Mexiletine Hydrochloride Market
18.1. France Mexiletine Hydrochloride Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Mexiletine Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Mexiletine Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Mexiletine Hydrochloride Market
19.1. Italy Mexiletine Hydrochloride Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Mexiletine Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Mexiletine Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Mexiletine Hydrochloride Market
20.1. Spain Mexiletine Hydrochloride Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Mexiletine Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Mexiletine Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Mexiletine Hydrochloride Market
21.1. Eastern Europe Mexiletine Hydrochloride Market Overview
21.2. Eastern Europe Mexiletine Hydrochloride Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Mexiletine Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Mexiletine Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Mexiletine Hydrochloride Market
22.1. Russia Mexiletine Hydrochloride Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Mexiletine Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Mexiletine Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Mexiletine Hydrochloride Market
23.1. North America Mexiletine Hydrochloride Market Overview
23.2. North America Mexiletine Hydrochloride Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Mexiletine Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Mexiletine Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Mexiletine Hydrochloride Market
24.1. USA Mexiletine Hydrochloride Market Overview
24.2. USA Mexiletine Hydrochloride Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Mexiletine Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Mexiletine Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Mexiletine Hydrochloride Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Mexiletine Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Mexiletine Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Mexiletine Hydrochloride Market
26.1. South America Mexiletine Hydrochloride Market Overview
26.2. South America Mexiletine Hydrochloride Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Mexiletine Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Mexiletine Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Mexiletine Hydrochloride Market
27.1. Brazil Mexiletine Hydrochloride Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Mexiletine Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Mexiletine Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Mexiletine Hydrochloride Market
28.1. Middle East Mexiletine Hydrochloride Market Overview
28.2. Middle East Mexiletine Hydrochloride Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Mexiletine Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Mexiletine Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Mexiletine Hydrochloride Market
29.1. Africa Mexiletine Hydrochloride Market Overview
29.2. Africa Mexiletine Hydrochloride Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Mexiletine Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Mexiletine Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Mexiletine Hydrochloride Market Competitive Landscape And Company Profiles
